China Universal Asset Management Company’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $798K | Buy |
5,804
+26
| +0.4% | +$3.57K | 0.08% | 193 |
|
|
2025
Q1 | $1.04M | Sell |
5,778
-320
| -5% | -$57.7K | 0.1% | 180 |
|
|
2024
Q4 | $955K | Buy |
6,098
+572
| +10% | +$89.6K | 0.09% | 165 |
|
|
2024
Q3 | $1.01M | Buy |
5,526
+2,172
| +65% | +$395K | 0.11% | 138 |
|
|
2024
Q2 | $616K | Sell |
3,354
-2,109
| -39% | -$387K | 0.09% | 131 |
|
|
2024
Q1 | $972K | Buy |
5,463
+2,204
| +68% | +$392K | 0.12% | 131 |
|
|
2023
Q4 | $404K | Buy |
3,259
+2,541
| +354% | +$315K | 0.08% | 156 |
|
|
2023
Q3 | $83.3K | Buy |
718
+379
| +112% | +$44K | 0.02% | 207 |
|
|
2023
Q2 | $39.8K | Sell |
339
-10
| -3% | -$1.17K | 0.01% | 214 |
|
|
2023
Q1 | $27.9K | Buy |
349
+87
| +33% | +$6.97K | 0.01% | 189 |
|
|
2022
Q4 | $20.8K | Buy |
262
+22
| +9% | +$1.74K | 0.01% | 171 |
|
|
2022
Q3 | $17K | Buy |
+240
| New | +$17K | 0.01% | 164 |
|